| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.0081 |
0.9 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |